Page 1586 - Small Animal Internal Medicine, 6th Edition

1558 Index

Feline chronic rhinosinusitis (Continued) Feline leukemia virus, 1494–1498. see Fiber-responsive large bowel diarrhea, Folate, 423–424, 1364
diagnosis of, 267 also Leukemias 494 Follicular cysts, 954, 954f
etiology of, 266–267 clinical features of, 1495–1496 Fiber-supplemented diets, 435 Follicular ovarian cysts, 1034t–1036t
VetBooks.ir Feline coronaviral enteritis, 479 enzyme-linked immunosorbent assay Fibrin, 1388 anatomy of, 1037
Forebrain
radiographic signs of, 249b
Fibric acid derivatives, 913
diagnosis of, 1496–1497
treatment of, 267–268, 267b
Fibrin degradation products, 222, 231,
lesions of, 1038b
detection of, 1497
Feline coronavirus, 1488–1491
1388
erythropoiesis and, 1353
clinical features of, 1488–1489 epidemiology of, 1494–1495 Fibrinogen, 221–222 Foreign objects
esophageal, 417, 418f, 428f, 458–459,
diagnosis of, 1489–1490 etiology of, 1494–1495 Fibrinolysis 458f
enteric, 1488 leukemia caused by, 1319 activation of, 1388 gastric, 466–467
epidemiology of, 1488 lymphoma secondary to, 1294, 1295t defective, 223 nasal, 240, 249b
etiology of, 1488 neoplasia caused by, 1495–1496 Fibrinolytic agents, 356 Forelimb hopping, 1048f
prevention of, 1491 outcomes of, 1495t Fibroblast growth factor receptor, 1273 Formalin-ether sedimentation technique,
treatment of, 1490–1491 panleukopenia and, 479–480 Fibroblast growth factor-23 (FGF-23), 573b
zoonotic aspects of, 1491 pregnancy loss and, 966 659–660, 695–696 Fort dodge. see Deslorelin
Feline eosinophilic granuloma, 449–450 prevention of, 1497–1498 Fibrocartilaginous embolism, 1141–1142 Fossa ovalis, 111
Feline fragile skin syndrome, 752, 894f replication of, 1495 Fibromatous epulis, 448t Fourth heart sound, 9
Feline granulocytotropic anaplasmosis, screening for, 1497 Fibrosarcoma, 448t, 1334 “Foxtail” grass, 241f
1471–1472, 1472f tests for, 243 Fibrosing pleuritis, 374 Fractional clearance of electrolytes, 664
Feline hepatic lipidosis, 561–567 transmission of, 1494–1495 Film digestion tests, 399 Fractional shortening, 25
Feline hepatocytes, 564f treatment of, 1497 Finasteride, 1001–1002, 1034t–1036t Fragile skin syndrome, 752, 894f
Feline herpesvirus vaccine for, 1453–1454 Fine-needle aspiration Francisella tularensis, 1533t–1535t, 1541
clinical features of, 257 zoonotic aspects of, 1497–1498 anterior mediastinal masses, 1291 Frank-Starling mechanism, 55
corneal ulcers caused by, 258 Feline leukemia virus-panleukopenia-like description of, 429, 1257–1258 Free fatty acids, 840
description of, 257 syndrome, 479–480 feline hepatic lipidosis, 562–564 Free radicals, 151
treatment of, 258 Feline lower urinary tract disease hemangiosarcoma, 1323 Frequency-domain analysis, 48
vaccines for, 258–259, 1453 (FLUTD), 724 lymphoma, 1299 Frontal sinus
Feline hippocampal necrosis, 1077–1078 Feline lymphocytic-plasmacytic Firocoxib, 1197t, 1209t–1210t, 1268t exploration of, 252
Feline hypertriglyceridemia, 912t gingivitis, 450–451 First heart sound, 5 radiographic imaging of, 247, 248f
Feline hypokalemic polymyopathy, Feline mammary fibroadenomatous First-degree atrioventricular block, Fructosamines, 818–819, 819t, 822, 837
1178–1179, 1178f hyperplasia, 979, 979f 43–44, 44f, 88 Full-thickness biopsy, 430
Feline idiopathic cystitis (FIC), 724–729 Feline monocytotropic ehrlichiosis, First-order neurons, 1089–1090 Fulminant congestive heart failure, 61
bladder abnormalities associated with, 1477–1478 Flaccid paralysis, 1438–1439 Fundic examination, 242
724 Feline nasopharyngeal polyps, 264, 264f Flagellates, 1538–1539 Fungal arthritis, 1201
chronic management of, 727–729 Feline panleukopenia virus, 1453 Flagyl. see Metronidazole Fungal diseases. see Mycotic infections
drug therapy for, 728–729, 728b pregnancy loss and, 966 Flecainide Fungal pneumonia, 344
environmental alterations for, 727–728 Feline parvoviral enteritis, 478–479 description of, 93 Fungi, 1541
histopathology of, 724 Feline periosteal proliferative in dogs, 90t–91t Fungizone. see Amphotericin B
infectious agents that cause, 724–725 polyarthritis, 1208, 1208t dosage of, 90t–91t Furosemide, 386t–388t, 691, 934t
multimodal environmental Feline plague, 1460–1462, 1461f, 1461b, Flexible endoscopy, 424 adverse effects of, 146–147
modifications for, 727–728, 1541 Flomax. see Tamsulosin chronic heart failure treated with, 64t,
728b Feline polioencephalitis, 1122–1123 Florfenicol, 1437t–1438t 66, 73
nonobstructive, 727 Feline rheumatoid-like arthritis, Florinef. see Fludrocortisone acetate congestive heart failure treated with,
nonulcerative, 724 1208–1209 Fluconazole, 1128, 1504t, 1509 164
obstructive, 726–727, 726f–727f Feline syncytium-forming virus, 1208 Flucytosine, 1504t, 1509 dilated cardiomyopathy treated with,
pathophysiology of, 724–725 Feline toxoplasmosis, 1521–1525 Fludrocortisone acetate, 888, 896t–897t 145
pheromones for, 728 Feline viral-associated pregnancy loss, Fluid heart failure treated with, 61, 128
systemic abnormalities associated 966 extracellular, 844f neurologic disorders treated with,
with, 725 Feminization, 997 intracellular, 844f 1185t–1186t
treatment of, 726–729 Femoral nerve, 1158t Fluid accumulation, 6 pulmonary edema and, 358, 382
ulcerative, 724 Femoral pulses, 5 Fluid therapy, 432–434 respiratory distress treated with, 166
Feline idiopathic polymyositis, Fenbendazole, 386t–388t, 515t–517t colloids, 433 G
1176–1177 Aelurostrongylus abstrusus treated diabetic ketoacidosis treated with,
Feline idiopathic vestibular syndrome, with, 345 842–845, 842b Gabapentin, 1034t–1036t, 1103–1104,
1114 Capillaria aerophila treated with, 344 fluid calculations, 434 1185t–1186t, 1197t, 1209t–1210t
Feline immune-mediated dosage of, 444t hyperkalemia treated with, 921 Gag reflex, 1056t
thrombocytopenia, 1244 nasal capillariasis treated with, hypertonic saline solution, 432–433 Gagging, in laryngeal diseases, 271
Feline immunodeficiency virus, 263–264 in hypoproteinemic animals, 434 Gait
1491–1494 Paragonimus kellicotti treated with, 345 leptospirosis treated with, 1464 evaluation of, 1045–1046
clinical features of, 1492 Fenoldopam, 691–692 overhydration, 433 hypermetric, 1038–1039, 1074–1075
diagnosis of, 1492–1493 Fentanyl citrate, analgesic uses of, 227b in protein-losing enteropathy, 434 Galactostasis, 978, 978f
diarrhea associated with, 480 Fentanyl patch, 629t–630t Flumethasone, 1222t Galastop. see Cabergoline
encephalopathy, 1123 Fetal heart rate monitoring, 973f Fluorescence in situ hybridization, 1431 Gallbladder mucocele, 600–601, 600f
epidemiology of, 1491–1492 Fetus Fluoroscopy Gallop rhythm, 9
etiology of, 1491–1492 age determination of, 950–951, 951f, idiopathic gastric hypomotility, 469 Gallop sounds, 9
lymphoma risks, 1294 951b larynx and pharynx, 273 Gastric acid secretion inhibitors, 439t
pregnancy loss and, 966 dystocia caused by anomalies of, 969, pharyngeal dysphagia evaluations, 452 Gastric antral mucosal hypertrophy, 465,
prevention of, 1494 970f–971f tracheal collapse evaluations, 335 466f
primary, 1492 Fever Fluoxetine, 728b Gastric dilation/volvulus, 419, 467–468
syndromes associated with, 1492, description of, 1423 Flush, nasal, 254 clinical features of, 467
1493t familial Chinese Shar-Pei, 1205, 1245t Fluticasone propionate, 331 diagnosis of, 467, 468f
tests for, 243 of undetermined origin, 1423 Focal gastritis, 427f etiology of, 467
transmission of, 1491–1492 causes of, 1424t Focal hepatic lesions, 612–615 prognosis of, 468
treatment of, 1493–1494 clinicopathologic evaluation of, abscesses, 612–613, 612f treatment of, 407–408, 467–468
vaccine for, 1454 1425–1426 neoplasia, 613–615, 613f, 614t Gastric emptying, 422
zoonotic aspects of, 1494 diagnostic approach to, 1424–1426, nodular hyperplasia, 613 Gastric foreign objects, 466–467
Feline infectious peritonitis, 514 1425b Focal neuropathies, 1157–1163 Gastric lavage, 1100b
ancillary tests for, 1118t disorders associated with, facial nerve paralysis, 1160, Gastric lymphoma, 463, 471
clinical findings of, 1489b 1423–1424 1160f–1161f Gastric neoplasms, gastrointestinal
description of, 1488 history and physical examination of, hyperchylomicronemia, 1162 ulceration/erosion from, 470
effusive, 1488, 1490f 1425 ischemic neuromyopathy, 1162–1163, Gastric outflow obstruction/gastric stasis,
nonseptic exudate and, 363 treatment of, 1426, 1426t 1163f 419f, 465–470
pregnancy loss and, 966 Fiber traumatic neuropathies, 1157, 1158t, benign muscular pyloric hypertrophy
signs of, 1126 description of, 445 1159f and, 465
vaccine for, 1454 diabetes mellitus in dogs managed trigeminal nerve paralysis, 1161–1162, bilious vomiting syndrome in, 470
Feline ischemic encephalopathy, 1077 with, 816 1162f diagnosis of, 465